EX-99.1 2 exhibit99-1.htm EXHIBIT 99.1 KWESST Micro Systems Inc.: Exhibit 99.1 - Filed by newsfilecorp.com

 

Condensed Consolidated Interim Financial Statements of

KWESST MICRO SYSTEMS INC.

 

Three and nine months ended June 30, 2023, and 2022
(Unaudited - Expressed in Canadian dollars)

 

 


KWESST MICRO SYSTEMS INC.

Table of contents for the three and nine months ended June 30, 2023, and 2022

  Page
FINANCIAL STATEMENTS  
Condensed Consolidated Interim Statements of Financial Position 3
Condensed Consolidated Interim Statements of Net Loss and Comprehensive Loss 4
Condensed Consolidated Interim Statements of Changes in Shareholders' Equity (Deficit) 5
Condensed Consolidated Interim Statements of Cash Flows 6
Notes to the Condensed Consolidated Interim Financial Statements 7-24


KWESST MICRO SYSTEMS INC.
Condensed Consolidated Interim Statements of Financial Position
At June 30, 2023 and September 30, 2022
(Unaudited)

In Canadian dollars   Notes        June 30,
2023
    September 30,
2022
 
                   
ASSETS                  
  Cash and cash equivalents       $ 1,759,688   $ 170,545  
  Restricted short-term investment         30,000     30,000  
  Trade and other receivables   5     298,058     171,882  
  Inventories   6     1,590,987     393,538  
  Prepaid expenses and other         1,251,143     122,166  
  Deferred share offering costs         36,733     628,262  
Current assets         4,966,609     1,516,393  
  Property and equipment         769,604     832,481  
  Right-of-use assets         251,885     208,131  
  Deposit         25,434     23,604  
  Intangible assets   7     4,986,583     4,742,854  
Non-current assets         6,033,506     5,807,070  
Total Assets       $ 11,000,115   $ 7,323,463  
                   
LIABILITIES AND SHAREHOLDERS' EQUITY                   
Liabilities                  
  Accounts payable and accrued liabilities   8 and 9   $ 2,460,099   $ 4,459,481  
  Accrued royalties liability         150,000     150,000  
  Lease obligations         95,419     69,150  
  Borrowings   10     -     2,199,978  
  Contract liabilities   11     328,678     47,271  
  Warrant liabilities   12 and 13(b)     3,027,148     -  
Current liabilities         6,061,344     6,925,880  
  Accrued royalties liability         1,094,206     1,115,207  
  Lease obligations         216,069     206,471  
  Borrowings   10     -     78,796  
Non-current liabilities         1,310,275     1,400,474  
Total Liabilities         7,371,619     8,326,354  
                   
Shareholders' Equity (Deficit)                  
  Share capital   13(a)     30,950,307     19,496,640  
  Warrants   13(b)     2,089,388     1,959,796  
  Contributed surplus   13(c)     3,460,772     3,551,330  
  Accumulated other comprehensive loss         (75,281 )   (101,418 )
  Accumulated deficit         (32,796,690 )   (25,909,239 )
Total Shareholders' Equity (Deficit)         3,628,496     (1,002,891 )
                   
Total Liabilities and Shareholders' Equity (Deficit)       $ 11,000,115   $ 7,323,463  

See Note 2(a) Going concern and Note 19 Commitments and contingencies.

See accompanying notes to the unaudited condensed consolidated interim financial statements.

On behalf of the Board of Directors:

(signed) John McCoach, Director (signed) David Luxton, Director


KWESST MICRO SYSTEMS INC.
Condensed Consolidated Interim Statements of Net Loss and Comprehensive Loss
Three and nine months ended June 30, 2023 and 2022
(Unaudited)

In Canadian dollars   Notes     Three Months
Ended
June 30,

2023
    Three Months
Ended
June 30,
2022
    Nine Months
Ended
June 30,

2023
    Nine Months
Ended
June 30,
2022
 
                               
                               
Revenue   15   $ 150,269   $ 282,432   $ 629,005   $ 466,148  
Cost of sales         (113,471 )   (238,350 )   (381,689 )   (405,841 )
Gross profit         36,798     44,082     247,316     60,307  
                               
Operating expenses                              
  General and administrative          1,802,054     1,322,730     4,446,512     3,410,887  
  Selling and marketing         731,543     851,705     2,338,646     2,931,460  
  Research and development, net         457,028     350,689     1,026,537     1,610,445  
Total operating expenses         2,990,625     2,525,124     7,811,695     7,952,792  
                               
Operating loss         (2,953,827 )   (2,481,042 )   (7,564,379 )   (7,892,485 )
                               
Other income (expenses)                              
  Share issuance costs         -     -     (1,309,545 )   -  
  Net finance costs   16     (40,826 )   (184,177 )   (595,510 )   (304,298 )
  Foreign exchange gain (loss)         24,332     22,901     (125,708 )   22,602  
  Change in fair value of warrant liabilities   12     (481,704 )   -     2,707,691     -  
  Loss on disposals         -     -     -     (1,165 )
  Gain on acquisition         -     41,869     -     41,869  
Total other income (expenses), net         (498,198 )   (119,407 )   676,928     (240,992 )
                               
Net loss        $ (3,452,025 ) $ (2,600,449 ) $ (6,887,451 ) $ (8,133,477 )
                               
Other comprehensive income:                              
                               
Items that are or may be reclassified subsequently to profit or loss:                              
  Foreign currency translation differences         4,713     (34,171 )   26,137     (19,132 )
Total comprehensive loss       $ (3,447,312 ) $ (2,634,620 ) $ (6,861,314 ) $ (8,152,609 )
                               
Net loss per share                              
  Basic and diluted       $ (0.81 ) $ (3.50 ) $ (2.04 ) $ (11.32 )
                               
Weighted average number of shares outstanding                              
  Basic and diluted   14     4,272,663     742,697     3,374,705     718,400  


KWESST MICRO SYSTEMS INC.
Condensed Consolidated Interim Statements of Changes in Shareholders' Equity (Deficit)
Nine months ended June 30, 2023, and 2022
(Unaudited)

In Canadian dollars                                                
    Notes     Share capital      Contingent
shares
    Warrants     Contributed
surplus
    Translation
reserve
    Deficit     Total
Shareholders'
Equity (Deficit)
 
Balance, September 30, 2021       $ 17,215,068   $ -   $ 1,848,389   $ 2,458,211   $ (8,991 ) $ (15,388,949 ) $ 6,123,728  
Shares issued to settle debt         19,000     -     -     -     -     -     19,000  
Shares and warrants issued on acquisition   4     377,503     83,319     132,000     -     -     -     592,822  
Contingent shares converted to common shares   4     83,319     -             83,319     -     -     -     -     -  
Warrants exercised         277,098     -     (61,173 )   -     -     -     215,925  
Warrants expired         -     -     (17,161 )   17,161     -     -     -  
Share-based compensation   13(c)     -     -     -     1,875,392     -     -     1,875,392  
Shares for vested RSUs and PSUs         854,181     -     -     (854,181 )   -     -     -  
Vested RSUs and PSUs repurchased for
withholding taxes
        -     -     -     (22,815 )   -     -     (22,815 )
Shares issued for unsecured loans         365,888     -     -     -     -     -     365,888  
Share offering costs         (26,323 )   -     -     -     -     -     (26,323 )
Other comprehensive income         -     -     -     -     (19,132 )   -     (19,132 )
Net loss          -     -     -     -     -     (8,133,477 )   (8,133,477 )
Balance, June 30, 2022       $ 19,165,734   $ -   $ 1,902,055   $ 3,473,768   $ (28,123 ) $ (23,522,426 ) $ 991,008  
                                                 
Balance, September 30, 2022       $ 19,496,640   $ -   $ 1,959,796   $ 3,551,330   $ (101,418 ) $ (25,909,239 ) $ (1,002,891 )
Shares issued for public offering   13(a)     13,675,120     -     -     -     -     -     13,675,120  
Share offering costs   13(a)     (3,050,278 )   -     189,592     125,086     -     -     (2,735,600 )
Shares issued for debt   13(a)     233,485     -     -     -     -     -     233,485  
Options exercised   13(c)     5,836     -     -     (1,789 )   -     -     4,047  
Warrants exercised   13(b) and 18     60,000     -     (60,000 )   -     -     -     -  
Share-based compensation   13(c)     -     -     -     316,261     -     -     316,261  
Shares for vested RSUs and PSUs   18     529,504     -     -     (529,504 )   -     -     -  
Vested RSUs and PSUs repurchased for
withholding taxes
        -     -     -     (612 )   -     -     (612 )
Other comprehensive income         -     -     -     -     26,137     -     26,137  
Net loss          -     -     -     -     -     (6,887,451 )   (6,887,451 )
Balance, June 30, 2023       $ 30,950,307   $ -   $ 2,089,388   $ 3,460,772   $ (75,281 ) $ (32,796,690 ) $ 3,628,496  

See accompanying notes to the unaudited condensed consolidated interim financial statements.


KWESST MICRO SYSTEMS INC.
Condensed Consolidated Interim Statements of Cash Flows
Nine months ended June 30, 2023, and 2022
(Unaudited)

In Canadian dollars   Notes     Nine months
ended
June 30, 2023
    Nine months
ended
June 30, 2022
 
                   
OPERATING ACTIVITIES                  
Net loss       $ (6,887,451 ) $ (8,133,477 )
Items not affecting cash:                  
Depreciation and amortization         609,634     225,308  
Share-based compensation   13(c)     316,261     1,875,392  
Change in fair value of warrant liabilities (including related foreign exchange gain)   12     (2,788,423 )   -  
Net finance costs   16     621,022     304,298  
Loss on disposals         -     1,165  
Gain on acquisition   4     -     (41,869 )
Changes in non-cash working capital items   18     (3,091,998 )   1,886,747  
Interest paid         (125,364 )   (65,316 )
Cash used in operating activities         (11,346,319 )   (3,947,752 )
                   
INVESTING ACTIVITIES                  
Additions of property and equipment         (243,528 )   (172,158 )
Investments in intangible assets   7     (598,525 )   (764,067 )
Deposit for advanced royalties         (148,410 )   -  
Recognition of open orders from acquisition   7     -     159,650  
Cash acquired on acquisition   4     -     162,547  
Cash flows used in investing activities         (990,463 )   (614,028 )
                   
FINANCING ACTIVITIES                  
Proceeds from U.S. IPO and Canadian Offering, net   13(a)     16,346,768     -  
Payments of share offering costs   13(a) and 18     (125,397 )   (26,323 )
Proceeds from borrowings   10     -     2,000,000  
Payments of deferred financing fees         -     (74,055 )
Repayment of borrowings         (2,333,315 )   -  
Repayments of lease obligations         34,430     (29,470 )
Proceeds from exercise of warrants         -     215,925  
Proceeds from exercise of stock options         4,052     -  
Repurchase of vested RSUs and PSUs for withholding taxes         (612 )   (22,815 )
Cash flows provided by financing activities         13,925,926     2,063,262  
                   
Net change in cash during the period         1,589,143     (2,498,518 )
Cash, beginning of period         170,545     2,688,105  
                   
Cash, end of period       $ 1,759,688   $ 189,587  
                   
Cash and cash equivalents consist of the following:                  
Cash held in banks         (1,270,262 )   189,587  
Short-term guaranteed investment certificates         3,029,950     -  
Cash and cash equivalents         1,759,688     189,587  

See Note 18 Supplemental cash flow information.

See accompanying notes to the unaudited condensed consolidated interim financial statements.     


KWESST MICRO SYSTEMS INC.
Notes to Condensed Consolidated Interim Financial Statements
Three and nine months ended June 30, 2023, and 2022
(Expressed in Canadian dollars, except share amounts)

1. Corporate information

a) Corporate information

KWESST Micro Systems Inc. (the "Company", "KWESST", "we", "our", and "us") was incorporated on November 28, 2017, under the laws of the Province of British Columbia. Our registered office is located at 550 Burrard Street, Suite 2900, Vancouver, British Columbia, Canada and our corporate office is located at Unit 1, 155 Terrence Matthews Crescent, Ottawa, Ontario, Canada. We have representative offices in the following foreign locations: Washington DC (United States), London (United Kingdom), and Abu Dhabi (United Arab Emirates).

We develop and commercialize next-generation technology solutions that deliver a tactical advantage for military, public safety agencies and personal defense markets.  Our core mission is to protect and save lives.

KWESST's common stock is listed on the TSX-Venture Exchange ("TSX-V'') under the stock symbol of KWE, on the Nasdaq Capital Market ("Nasdaq") under the stock symbol of KWE and on the Frankfurt Stock Exchange under the stock symbol of 62U.  Additionally, warrants issued in the United States are also listed on the Nasdaq under the stock symbol of KWESW. Effective May 1, 2023, the warrants issued in Canada are listed on the TSX-V under the stock symbol of KWE.WT.U.

b) Reverse Stock Split

In August 2022, we submitted a Form F-1 Registration Statement to the U.S. Securities and Exchange Commission and applied to have its common shares listed on Nasdaq. In connection with KWESST's listing application on Nasdaq, we effected a one for seventy (1-for-70) reverse stock split of its common stock on October 28, 2022 (the "Reverse Split").  Accordingly, all shareholders of record at the opening of business on October 28, 2022, received one issued and outstanding common share of KWESST in exchange for seventy outstanding common shares of KWESST.  No fractional shares were issued in connection with the Reverse Split.  All fractional shares created by the Reverse Split were rounded to the nearest whole number of common shares, with any fractional interest representing 0.5 or more common shares entitling holders thereof to receive one whole common share. 

Effective on the date of the Reverse Split, the exercise price and number of common shares issuable upon the exercise of outstanding stock options were proportionately adjusted to reflect the Reverse Split. The restricted share units ("RSUs") and performance stock units ("PSUs") have also been adjusted for the Reverse Split.  While the number of warrants has not changed as a result of the Reverse Split; the conversion rate for each warrant was adjusted from one common share to 0.01428571 common share.  All information respecting outstanding common shares and other securities of KWESST, including net loss per share, in the current and comparative periods presented herein give effect to the Reverse Split.

2. Basis of preparation

(a) Going concern

These unaudited condensed consolidated interim financial statements have been prepared assuming we will continue as a going concern.

As an early-stage company, we have not yet reached commercial production for most of our products and have incurred significant losses and negative operating cash flows from inception that have primarily been funded from financing activities. We have incurred a $6.9 million net loss and negative operating cash flows of $11.3 million for the nine months ended June 30, 2023 (2022 - $8.1 million net loss and negative operating cash flows of $3.9 million). At June 30, 2023, we had negative $1.1 million in working capital (September 30, 2022 - negative $5.4 million). 


KWESST MICRO SYSTEMS INC.
Notes to Condensed Consolidated Interim Financial Statements
Three and nine months ended June 30, 2023, and 2022
(Expressed in Canadian dollars, except share amounts)

Our ability to continue as a going concern and realize our assets and discharge our liabilities in the normal course of business is dependent upon closing timely additional sales orders, timely commercial launch of new products, and the ability to raise additional debt or equity financing, when required. There are various risks and uncertainties affecting our future financial position and our performance including, but not limited to:

  • The market acceptance and rate of commercialization of our product offerings;
  • Ability to successfully execute our business plan;
  • Ability to raise additional capital at acceptable terms;
  • General local and global economic conditions, including the ongoing COVID-19 pandemic and the global disruption from Russia's invasion of Ukraine.

Our strategy to mitigate these material risks and uncertainties is to execute timely a business plan aimed at continued focus on revenue growth, product development and innovation, improving overall gross profit, managing operating expenses and working capital requirements, and securing additional capital, as needed.

Failure to implement our business plan could have a material adverse effect on our financial condition and/or financial performance. There is no assurance that we will be able to raise additional capital as they are required in the future. Accordingly, there are material risks and uncertainties that may cast significant doubt about our ability to continue as a going concern.

These condensed consolidated interim financial statements do not include any adjustments to the carrying amounts and classification of assets, liabilities and reported expenses that may otherwise be required if the going concern basis was not appropriate.

(b) Statement of compliance

These unaudited condensed consolidated interim financial statements have been prepared in accordance with IAS 34, Interim Financial Reporting, ("IAS 34") as issued by the International Accounting Standards Board ("IASB").  They do not include all the information required for a complete set of financial statements prepared in accordance with International Financial Reporting Standards ("IFRS") and should be read in conjunction with our annual consolidated financial statements for the year ended September 30, 2022. However, selected explanatory notes are included to explain events and transactions that are significant to an understanding of the changes in our financial position and performance since the last annual consolidated financial statements as at and for the year ended September 30, 2022.

These unaudited condensed consolidated interim financial statements were authorized for issue by the Board of Directors on August 14, 2023.

(c) Basis of consolidation

These unaudited condensed consolidated interim financial statements incorporate the financial statements of KWESST and the entities it controls.

Control is achieved where we have the power to govern the financial and operating policies of an entity so as to obtain benefits from its activities, are exposed to, or have rights to, variable returns from our involvement with the entity and have the ability to affect those returns through its power over the entity. Subsidiaries are fully consolidated from the date on which control is transferred to us until the date on which control ceases. Profit or loss of subsidiaries acquired during the year are recognized from the date of acquisition or effective date of disposal as applicable. All intercompany transactions and balances have been eliminated.


KWESST MICRO SYSTEMS INC.
Notes to Condensed Consolidated Interim Financial Statements
Three and nine months ended June 30, 2023, and 2022
(Expressed in Canadian dollars, except share amounts)

At June 30, 2023, we have the following wholly owned subsidiaries:

  Location Equity %
KWESST Inc. Ottawa, Canada 100%
2720178 Ontario Inc. Bowmanville, Canada 100%
Police Ordnance Company Inc. Bowmanville, Canada 100%
KWESST U.S. Holdings Inc. Delaware, Canada 100%
KWESST Defense Systems U.S. Inc. Virginia, United States 100%
KWESST Public Safety Systems U.S. Inc. Virginia, United States 100%
KWESST Public Safety Systems Canada Inc. Ottawa, Canada 100%

(d) Functional and presentation currency

These financial statements are presented in Canadian dollars ("CAD"), our functional currency and presentation currency.

(e) Basis of measurement

The consolidated financial statements have been prepared on the historical cost basis except for certain financial instruments measured at fair value. Historical cost is generally based on the fair value of the consideration given in exchange for assets.

(f) Use of estimates and judgments

The preparation of the unaudited condensed consolidated interim financial statements in accordance with IFRS requires management to make judgments, estimates, and assumptions that affect the application of accounting policies and the reported amounts of assets and liabilities, income, expenses, and disclosure of contingent liabilities.  Actual results may differ from these estimates.

Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to estimates are recognized prospectively.

Judgments

Information about judgments made in applying accounting policies that have the most significant effects on the amounts recognized in these consolidated financial statements are the same as disclosed in Note 2(f) of the consolidated financial statements for the year ended September 30, 2022, except for the following new item:

  • Note 12 - warrant liabilities: whether the determination of our stock volatility and the expected life of the warrant liabilities are reasonable considering our limited operating history, both are significant inputs in the valuation model to fair value the warrant liabilities issued in the U.S IPO and Canadian Offering.

Estimates

Information about assumptions and estimation uncertainties at June 30, 2023, that have a significant risk of resulting in a material adjustment to the carrying amounts of assets and liabilities in the next financial year are the same as disclosed in Note 2(f) of the audited consolidated financial statements for the year ended September 30, 2022.


KWESST MICRO SYSTEMS INC.
Notes to Condensed Consolidated Interim Financial Statements
Three and nine months ended June 30, 2023, and 2022
(Expressed in Canadian dollars, except share amounts)

COVID-19 Uncertainties

There is no change to our COVID-19 assessment from the disclosure provided in Note 2(f) of the audited consolidated financial statements for the year ended September 30, 2022.

3. Significant accounting policies

During the nine months ended June 30, 2023, the accounting policies in these condensed consolidated interim financial statements are the same as those applied in KWESST's consolidated financial statements as at and for the year ended September 30, 2022.

4. Acquisition

On December 15, 2021, we acquired 2720178 Ontario Inc., an Ontario (Canada) corporation, which owns all of the issued and outstanding shares of Police Ordnance Company Inc., an Ontario (Canada) corporation (together, "Police Ordnance"), herein referred as the "Police Ordnance Acquisition". Located in Bowmanville, Ontario, with ancillary operations in Florida, Police Ordnance owns all intellectual properties to the ARWENTM product line of launchers, and a proprietary line of 37 mm cartridges designed for riot control and tactical teams.  Police Ordnance has law enforcement customers across Canada, the United States, and abroad. The Police Ordnance Acquisition provides us with a strategic opportunity to leverage its law enforcement customer base to accelerate growth within its specialty ordnance business.

We accounted for the acquisition of Police Ordinance pursuant to IFRS 3, Business Combinations.

Consideration Transferred:

The purchase consideration comprised of the following:

    Number     Fair Value  
Common shares    3,965   $ 377,503  
Warrants   200,000   $ 132,000  
Contingent shares   875   $ 83,319  
Total fair value purchase consideration       $ 592,822  

The warrants are exercisable at $1.72 each and will expire on December 15, 2024. As a result of the Reverse Split (see Note 1(b)), each warrant converts into 0.01428571 common share or 70 warrants to receive one common share of KWESST.

We issued the 875 contingent common shares to the sellers in April 2022 following the fulfillment of the financial milestone as defined in the share purchase agreement.

We have estimated the fair value as follows:

  • Common shares: based on KWESST's closing stock price on December 15, 2021.
  • Warrants: based on using the Black Scholes option model with the following key inputs: a) exercise price of $1.72, 1/70 of the underlying stock price of $1.36, risk free rate of 1.04%, expected life of three years, and expected volatility of 84.7%.
  • Contingent shares: based on KWESST's closing stock price on December 15, 2021, and high probability of achieving the financial milestone as defined in the share purchase agreement.

KWESST MICRO SYSTEMS INC.
Notes to Condensed Consolidated Interim Financial Statements
Three and nine months ended June 30, 2023, and 2022
(Expressed in Canadian dollars, except share amounts)

The net cash inflow as at the closing of the acquisition was as follows:

Cash assumed on acquisition $ 162,547  
less: consideration paid in cash   -  
Net cash inflow on acquisition $ 162,547  

Net Assets Acquired:

The purchase consideration was allocated to Police Ordnance's net assets as follows:

Total purchase consideration at fair value $ 592,822  
       
Police Ordnance's net assets:      
Cash   162,547  
Trade and other receivables   104,432  
Inventories   352,685  
Intangible assets:      
   Purchase orders   100,000  
   Customer relationships   50,000  
   ARWENTM tradename   44,000  
Accounts payable and accrued liabilities   82,963  
Corporate tax liability   32,338  
Contract liabilities   29,861  
Borrowings   26,238  
Deferred tax liabilities   49,442  
Net assets at fair value $ 592,822  

As a result of the above purchase price allocation, we have recorded no goodwill for the Police Ordnance Acquisition.

Impact on KWESST's Results of Operations:

The results of operations of Police Ordnance are included in these unaudited condensed consolidated interim statements of net loss and comprehensive loss from December 16, 2021. If the acquisition had occurred on October 1, 2021, management estimates that Police Ordnance would have contributed approximately $341,500 and $623,800 of revenue and approximately $51,600 and $2,500 of net profit to KWESST's operating results for the three and nine months ended June 30, 2022, respectively. In determining these amounts, management has assumed that the fair value adjustments that arose on the date of the acquisition would have been the same if the acquisition had occurred on October 1, 2021.

We incurred immaterial acquisition-related costs.


KWESST MICRO SYSTEMS INC.
Notes to Condensed Consolidated Interim Financial Statements
Three and nine months ended June 30, 2023, and 2022
(Expressed in Canadian dollars, except share amounts)

5. Trade and other receivables

The following table presents trade and other receivables for KWESST:

    June 30, 
2023
    September 30,
2022
 
Trade receivables $ 109,965   $ 114,877  
Unbilled revenue   5,211     8,881  
Sales tax recoverable   182,882     48,124  
Other receivable   -     -  
Total  $ 298,058   $ 171,882  

There was no impairment of trade and other receivables during the six months ended June 30, 2023 (2022 - $nil).

The following table presents changes in unbilled receivables:

    June 30, 
2023
    September 30,
2022
 
Balance, beginning of period $ 8,881   $ 308,728  
Revenue billed during the period   (3,670 )   (308,728 )
Revenue in excess of billings, net of amounts transferred to trade receivables   -     8,881  
Balance, end of period $ 5,211   $ 8,881  
Current $ 5,211   $ 8,881  
Non-current $ -   $ -  

6. Inventories

The following table presents a breakdown of inventories: 

        June 30,
2023
    September 30,
2022
 
Finished goods $ 53,732   $ 49,643  
Work-in-progress   922,324     21,350  
Raw materials   614,931     322,545  
Total  $ 1,590,987   $ 393,538  

There was no impairment of inventories during the nine months ended June 30, 2023 (2022 - $nil).


KWESST MICRO SYSTEMS INC.
Notes to Condensed Consolidated Interim Financial Statements
Three and nine months ended June 30, 2023, and 2022
(Expressed in Canadian dollars, except share amounts)

7. Intangible assets

The following table shows the movement in intangible assets since September 30, 2022:

Cost   PhantomTM
System
    PARA
OPSTM
System
    PARA
OPSTM
Patent
    ARWENTM
Tradename
    Customer
Relationships
    Purchase
Orders
    Total  
Balance at September 30, 2022 $ 1,149,585   $ 3,469,215   $ 28,783   $ 37,032   $ 46,041   $ 12,198   $ 4,742,854  
Additions   19,855     570,414     8,256     -     -     -     598,525  
Amortization   -     (336,635 )   -     (6,600 )   (3,750 )   -     (346,985 )
Recognition of open orders    -     -     -     -     -     (7,811 )   (7,811 )
Balance at June 30, 2023 $ 1,169,440   $ 3,702,994   $ 37,039   $ 30,432   $ 42,291   $ 4,387   $ 4,986,583  

At June 30, 2023, management concluded there was no impairment on the intangible assets (2022 - $nil). The development of PARA OPSTM was substantially completed during the six months ended March 31, 2023, and amortization of $336,635 was recognized in General and administrative expenses. Management determined the estimated useful life to be five years.

8. Accounts payable and accrued liabilities

The following table presents a breakdown of our accounts payable and accrued liabilities:

    June 30,
2023
    September 30,
2022
 
Trade payable $ 1,034,913   $ 2,292,954  
Accrued liabilities   1,157,241     1,045,409  
Salary and vacation payable   267,945     1,121,118  
Total  $ 2,460,099   $ 4,459,481  

9.  Related party transactions

At June 30, 2023, there was $264,959 (September 30, 2022 - $672,531) outstanding in accounts payable and accrued liabilities due to our officers and directors for unpaid wages, director fees, and expense reimbursements.

10. Borrowings

The following is a reconciliation of borrowings since September 30, 2022:

    CEBA Term
Loans
    March 2022
Loans
    August 2022
Loans
    Total
Borrowings
 
Balance, September 30, 2022 $ 78,796   $ 1,764,630   $ 435,348   $ 2,278,774  
Accrued interest and accretion expense   11,204     274,887     179,096     465,187  
Interest paid   -     (39,517 )   (63,661 )   (103,178 )
Repayment of principal   (70,000 )   (1,988,000 )   (275,315 )   (2,333,315 )
Settled in equity (Notes 12 and 18)   -     (12,000 )   (275,468 )   (287,468 )
Forgivable amount   (20,000 )   -     -     (20,000 )
Balance, June 30, 2023 $ -   $ -   $ -   $ -  

There were no changes to KWESST's RBC Credit Facility since September 30, 2022.


KWESST MICRO SYSTEMS INC.
Notes to Condensed Consolidated Interim Financial Statements
Three and nine months ended June 30, 2023, and 2022
(Expressed in Canadian dollars, except share amounts)

11. Contract liabilities

The following is a reconciliation of contract liabilities since September 30, 2022:

    June 30,  
    2023  
Balance, beginning of period $ 47,271  
Amounts invoiced and revenue deferred   328,678  
Recognition of deferred revenue included in the      
balance at the beginning of period   (47,271 )
Balance, end of period $ 328,678  

12. Warrant liabilities

The following is a reconciliation of warrant liabilities since September 30, 2022:

    U.S. IPO and Canadian Offering   Debt Settlement        
        Over-allotment                    
    2022     Pre-Funded     Over-allotment              
    Warrants     Warrants     Warrants     Warrants     Total  
Balance, beginning of period $ -   $ -   $ -   $ -   $ -  
Initial recognition   4,617,451     832,698     536,681     80,617     6,067,447  
(Gain) Loss on revaluation of financial instruments   (2,641,798 )   34,659     (305,270 )   (47,158 )   (2,959,567 )
Exchange gain on revaluation   (52,788 )   (20,026 )   (7,918 )   -     (80,732 )
Balance, end of period $ 1,922,865   $ 847,331   $ 223,493   $ 33,459   $ 3,027,148  
Number of outsanding securities as at June 30, 2023   3,226,392     199,000     375,000     56,141     3,856,533  

U.S. IPO and Canadian Offering

On December 9, 2022, we closed an underwritten U.S. public offering (the "U.S. IPO") and an underwritten Canadian offering (the "Canadian Offering") for aggregate gross proceeds of CAD$19.4 million (US$14.1 million) (see Note 13(a)). As part of the U.S. IPO and Canadian Offering, we have issued 3,226,392 warrants (the "2022 Warrants") with an exercise price of US$5.00 per share. Additionally, the U.S. underwriter exercised its over-allotment option to purchase:

 199,000 Pre-Funded Warrants with an exercise price of US$0.01 per share for $3.81024 per pre-funded warrant (net of underwriter discount);

 375,000 warrants with exercise price of US$5.00 per share for $0.0001 per warrant;

Refer to Note 13(a) for further information on the U.S. IPO and Canadian Offering.

Under IFRS, the above securities are classified as financial liabilities (referred herein as "warrant liabilities") because the exercise price is denominated in U.S. dollars, which is different to our functional currency (Canadian dollars). Accordingly, the ultimate proceeds in Canadian dollars from the potential exercise of the above securities are not known at inception. These financial liabilities are classified and measured at FVTPL (see Note 3(c) of the audited consolidated financial statements for the year ended September 30, 2022). Gains on revaluation of the warrant liabilities are presented in Other income (expenses) on the unaudited condensed consolidated interim statements of net loss and comprehensive loss.

Warrant liabilities

While the warrants issued in the U.S. IPO were listed on Nasdaq and closed at US$0.90 per warrant on December 9, 2022, management concluded that this closing price was not reflective of an active market due to short trading window and therefore not representative of fair value. Accordingly, at inception, the 2022 Warrants were measured at fair value using the Black Scholes option pricing model (Level 2). We used the following assumptions:


KWESST MICRO SYSTEMS INC.
Notes to Condensed Consolidated Interim Financial Statements
Three and nine months ended June 30, 2023, and 2022
(Expressed in Canadian dollars, except share amounts)

        Over-allotment        
    2022     Pre-Funded     Over-allotment  
    Warrants     Warrants (1)     Warrants (2)  
Number of dilutive securities   3,282,533     199,000     375,000  
Exercise price (in USD) $ 5.00   $ 0.01        
Share price (in USD) $ 4.13   $ 3.08        
Expected life   2.50              
Dividend $ -              
Volatility   75%              
Risk free rate   4.20%              
Exchange rate (USD/CAD) $ 1.363              
Fair value per warrant (CAD) $ 1.43   $ 4.18     1.43  

(1) Fair value is measured at the underlying common share closing price on Nasdaq on December 9, 2022, less US$0.01 exercise price.

(2) Same fair value as calculated for Warrants.

The share price (in USD) for the over-allotment pre-funded warrants was based on the estimated fair value of the common shares issued on December 9, 2022, by deducting the fair value of the warrants of US$1.05 from the US$4.13 Unit price and the exercise price of US$0.01 (see Note 13(a)).

Based on the above fair value, the issuance of the over-allotment pre-funded warrants and warrants to the underwriter resulted in a non-cash charge of $251,877, which is included in the change in fair value of warrant liabilities in the condensed consolidated interim statements of net loss and comprehensive loss.

At June 30, 2023, we remeasured the fair value of these warrants using the following assumptions:

        Over-allotment        
    2022     Pre-Funded     Over-allotment  
  Warrants (1)     Warrants (2)     Warrants (1)  
Number of securities   3,282,533     199,000     375,000  
Nasdaq closing price (in USD) $ 0.45   $ 3.23   $ 0.45  
Exchange rate (USD/CAD) $ 1.324   $ 1.324   $ 1.324  
Fair value per warrant (CAD) $ 0.60   $ 4.26   $ 0.60  

(1) Fair value is based on the Nasdaq closing pricing on June 30, 2023, for the warrants.

(2) Fair value is measured at the Nasdaq closing price on June 30, 2023, for the underlying common stock less US$0.01 exercise price.

Including the non-cash charge for the issuance of the over-allotment pre-funded warrants and warrants to the underwriter, we recognized $481,704 as a gain in fair value and $2,707,691 as a loss in fair value of warrant liabilities during the three and nine months ended June 30, 2023, respectively, which was reported in the condensed consolidated net loss and comprehensive loss.

December 2022 Debt Settlement

On December 13, 2022, we have entered into share for debt arrangements with existing lenders (see Note 13(a)), which resulted in issuing 56,141 Units, same terms as the Units as issued in the Canadian Offering except that the underlying securities are subject to a four-month hold period. Accordingly, this resulted in issuing 56,141 common shares and 56,141 warrant liabilities with an exercise price of US$5.00 per share and maturing on December 13, 2027. We initially recorded the fair value of the warrant liabilities using the Black Scholes option pricing model with an underlying stock price equivalent to the unit price of US$4.13.


KWESST MICRO SYSTEMS INC.
Notes to Condensed Consolidated Interim Financial Statements
Three and nine months ended June 30, 2023, and 2022
(Expressed in Canadian dollars, except share amounts)

At June 30, 2023, we remeasured the fair value of these warrant liabilities using the Nasdaq closing price on June 30, 2023, of US$0.45. The remeasurement resulted in a change in fair value of warrant liabilities of $4,726 and $47,158 for the three and nine months ended June 30, 2023, respectively, which was reported in the condensed consolidated net loss and comprehensive loss.

13. Share capital and Contributed Surplus

a) Share capital

Authorized

KWESST is authorized to issue an unlimited number of common shares.

Issued Common Shares

The following is a summary of changes in outstanding common shares since September 30, 2022:

    Number     Amount  
Balance at September 30, 2022   773,225   $ 19,496,640  
Issued for U.S. IPO and Canadian Offering   3,226,392   $ 13,675,120  
Issued for debt settlements   56,134   $ 233,485  
Issued for conversion of stock units   14,141   $ 529,504  
Issued for option exercise   1,125   $ 5,836  
Issued for warrant exercise   3,571   $ 60,000  
Less: share offering costs for the period       $ (3,050,278 )
Balance at June 30, 2023   4,074,588   $ 30,950,307  

U.S. IPO and Canadian Offering

On December 9, 2022, we closed the U.S. IPO and the Canadian Offering. In the U.S. IPO, we sold 2.5 million units at a public offering price of USD $4.13 per unit (the "Unit"), consisting of one share of common stock and one warrant to purchase one share of common stock ("Warrant"). The Warrants have a per share exercise price of USD $5.00 and can be exercised immediately. In connection with the closing of the U.S. IPO, the underwriter partially exercised its over-allotment option to purchase an additional 199,000 pre-funded common share purchase warrants ("Pre-Funded Warrants") at US$4.12 (before underwriter discount) and 375,000 option warrants to purchase common shares at US$0.0001 each. A Pre-Funded Warrant is a financial instrument that requires the holder to pay little consideration (exercise price of US$0.01) to receive the common share upon exercise of the Pre-Funded Warrant (see Note 14). The holder of Pre-Funded Warrants has no voting rights. All of these warrants expire on December 9, 2027.

In the Canadian Offering, we sold 726,392 units, each consisting of one common share and one warrant to purchase one common share, at a price to the public of USD $4.13 per unit. The warrants will have a per common share exercise price of USD $5.00, are exercisable immediately and expire in five years on December 9, 2027. Effective May 1, 2023, the warrants are listed on the TSX-V under the stock symbol of KWE.WT.U.

The closing of the U.S. IPO and Canadian Offering resulted in aggregate gross proceeds of CAD$19.4 million (USD $14.1 million), before deducting underwriting discounts and offering expenses.


KWESST MICRO SYSTEMS INC.
Notes to Condensed Consolidated Interim Financial Statements
Three and nine months ended June 30, 2023, and 2022
(Expressed in Canadian dollars, except share amounts)

The common shares of KWESST and the Warrants sold in the U.S. IPO began trading on the Nasdaq Capital Market under the symbols "KWE" and "KWESW", respectively, on December 7, 2022.

ThinkEquity acted as sole book-running manager for the U.S. IPO and PI Financial acted as sole book-running manager for the Canadian Offering.

Accounting Treatment

Refer to Note 12 for the accounting of the warrants issued in the U.S. IPO and Canadian Offering.

Brokers' Compensation and Share Offering Costs

As consideration for the services provided in connection with the U.S. IPO, ThinkEquity received: (a) a broker- dealer cash commission of US$835,000 (or CAD$1,138,105) equal to 7.5% of the gross offering proceeds of the U.S. Offering and (b) underwriter warrants (the "U.S. Underwriter Warrants") to purchase up to 134,950 common shares equal to 5% of the common shares and pre-funded common share purchase warrants issued under the U.S. Offering. Each U.S. Underwriter Warrant is exercisable to acquire one common share at a price of US$5.1625, exercisable as of June 4, 2023, and expiring on December 9, 2027.

As consideration for the services provided in connection with the Canadian Offering, PI Financial received: (a) a cash commission of approximately US$210,000 (or CAD$286,230); and (b) 50,848 compensation options (the "Canadian Compensation Options"). Each Canadian Compensation Option is exercisable to acquire one Canadian Unit at a price of US$4.13 and expiring on December 9, 2024.

In addition to the above brokers' compensation, we also incurred US$2.1 million share offering costs (or CAD$2.8 million) for the U.S. IPO and Canadian Offering, of which CAD$628,262 was incurred and deferred at September 30, 2022.

The total brokers compensation (including fair value of U.S. Underwriter Warrants and Canadian Compensation Options) and share offering costs was US$3.2 million (or CAD$4.4 million). This total was allocated proportionately to the fair value of common shares and warrant liabilities. Accordingly, CAD$1.3 million allocated to warrant liabilities were expensed during the nine months ended June 30, 2023.

Shares for Debt Settlement

We have entered into share for debt arrangements with existing lenders, which closed on December 13, 2022, following TSXV's conditional approval. This resulted in issuing 56,141 Units to settle $12,000 of the March 2022 Loans and USD$223,321 (or CAD$302,197) of the August 2022 Loans, including unpaid accrued interest and 10% premium at maturity (the "Debt Settlements") - see Note 10. The terms of the Units are the same as the Units issued in the Canadian Offering.


KWESST MICRO SYSTEMS INC.
Notes to Condensed Consolidated Interim Financial Statements
Three and nine months ended June 30, 2023, and 2022
(Expressed in Canadian dollars, except share amounts)

 

b) Warrants

The following is a summary of changes in outstanding warrants since September 30, 2022:

            Weighted  
      Number of     average  
      warrants     exercise price  
Outstanding at September 30, 2022     13,417,156   $ 0.78  
Issued (Note 13(a))     3,991,483   $ 6.44  
Exercised     (250,000 ) $ 0.50  
Outstanding at June 30, 2023     17,158,639   $ 2.10  
Exercisable at June 30, 2023     16,648,689   $ 2.09  

The table that follows outlines the ratio upon which the above warrants are converted into common shares.

U.S. Underwriter Warrants

In the U.S. IPO, we issued 134,950 warrants ("U.S. Underwriter Warrants"). Each U.S. Underwriter Warrant is exercisable to acquire one common share at US$5.1625 for a period of 5 years (expiring on December 9, 2027). Management estimated the fair value of these warrants using the Black Scholes option model with the following inputs:

Number of dilutive securities 134,950  
Exercise price (in USD) $ 5.16  
Share price (in USD) $ 3.08  
Expected life   2.50  
Dividend $ -  
Volatility   75%  
Risk free rate   4.20%  
Exchange rate (USD/CAD) $ 1.363  
Fair value per warrant (CAD) $ 1.40  

We have recorded $189,592 as the fair value for the U.S. Underwriter Warrants, with an equal offset to share offering costs (a non-cash transaction).


KWESST MICRO SYSTEMS INC.
Notes to Condensed Consolidated Interim Financial Statements
Three and nine months ended June 30, 2023, and 2022
(Expressed in Canadian dollars, except share amounts)

The following table provides additional information on the total outstanding warrants at June 30, 2023, see note 1(b):

                         
    Number     Conversion ratio to              
    outstanding     Common Shares     Book value     Expiry Date  
Classified as Equity                        
Founders' warrants:                        
Exercise price of $0.20   5,520,000     70 for 1   $ 1,013     January 1, 2024  
Exercise price of $0.20   1,900,000     70 for 1   $ 18,865     June 14, 2024  
April 2021 equity financing:                        
Exercise price of $1.75   3,274,657     70 for 1   $ 785,918     April 29, 2023  
Exercise price of $1.75   40,000     70 for 1   $ 9,600     August 25, 2023  
LEC's warrants:                        
Exercise price of $0.70   500,000     70 for 1   $ 425,000     April 29, 2026  
September 2021 equity financing:                        
Exercise price of $2.35   750,000     70 for 1   $ 390,000     September 16, 2023  
Broker warrants:                        
Exercise price of $1.75   137,499     70 for 1   $ 33,000     April 29, 2023  
Exercise price of $2.00   45,000     70 for 1   $ 32,400     September 16, 2023  
Acquisition of Police Ordnance (Note 4):                        
Exercise price of $1.72   200,000     70 for 1   $ 132,000     December 15, 2024  
July 2022 equity financing:                        
Exercise price of $0.285   800,000     70 for 1   $ 72,000     July 14, 2024  
December 2022 U.S. Underwriter Warrants                        
Exercise price of US$5.1625   134,950     1 for 1   $ 189,592     December 6, 2024  
    13,302,106         $ 2,089,388        
Classified as liability                        
December 2022 public offerings:                        
Exercise price of US$5.00   3,226,392     1 for 1   $ 1,922,865     December 9, 2027  
December 2022 Pre-Funded Warrants                        
Exercise price of US$0.01   199,000     1 for 1   $ 847,331     No expiry  
December 2022 Option Warrants                        
Exercise price of US$5.1625   375,000     1 for 1   $ 223,493     December 9, 2024  
December 2022 debt settlement                        
Exercise price of US$5.00   56,141     1 for 1   $ 33,459     December 9, 2027  
    3,856,533           3,027,148        
Total outstanding warrants   17,158,639         $ 5,116,536        

c) Contributed Surplus

Broker Compensation Options

In the Canadian Offering, we issued 50,848 Canadian Compensation Options. Each Canadian Compensation Option is exercisable to acquire one Unit, as defined in Note 13(a), at a price equal to US$4.13 for a period of two years (expiring on December 9, 2024). Based on the structure of the Compensation Option, management estimated its fair value using the Monte Carlo method (Level 2). We used the following key inputs in the Monte Carlo model (100,000 simulations):


KWESST MICRO SYSTEMS INC.
Notes to Condensed Consolidated Interim Financial Statements
Three and nine months ended June 30, 2023, and 2022
(Expressed in Canadian dollars, except share amounts)

    Initial  
  Recognition  
Number of securities   50,848  
Exercise price - compensation option (in USD) $ 4.13  
1-Year CAD/USD Forward Exchange Rate $ 1.3560  
Exercise price - compensation warrant (in USD) $ 5.00  
2-Year CAD/USD Forward Exchange Rate $ 1.3483  
Share price (in CAD) $ 4.20  
Expected life - compensation option   1.00  
Expected life - compensation warrant   2.50  
Dividend $ -  
Volatility - compensation option   90%  
Volatility - compensation warrant   75%  
Risk free rate - compensation option   4.38%  
Risk free rate - compensation warrant   3.15%  
Fair value per compensation option (CAD) $ 2.46  

We have recorded $125,086 of Canadian Compensation Options in contributed surplus, with an equal offset to share offering costs (a non-cash transaction).

Share-based compensation

On March 31, 2023, KWESST shareholders approved the renewal of the Long-Term Incentive Plan (the "LTIP"). Additionally, the disinterested shareholders of KWESST approved an amendment to the LTIP to increase the number of RSUs, PSUs, DSUs, and SARs (collectively "Share Units") authorized for issuance pursuant to the LTIP from 60,682 to 407,274 Share Units. Accordingly, we have 338,681 Share Units available for future grants.

Further, the disinterested shareholders of KWESST approved to revise the exercise price of 50,981 stock options to $3.60, the closing price of KWESST common shares on the TSX-V on March 31, 2023. In accordance with IFRS 2, this resulted in an immediate fair value increase of $77,001 included in share-based compensation, with an offset to contributed surplus for the three and six months ended March 31, 2023.

During the three and nine months ended June 30, 2023, we granted 10,000 stock options and did not grant any RSUs, PSUs, and SARs, pursuant to our LTIP during the nine months ended June 30, 2023. Accordingly, we had 59,907 outstanding stock options at June 30, 2023. The remaining available stock option pool for future grants was 347,551 at June 30, 2023.

For the three and nine months ended June 30, 2023, we recorded share-based compensation of $39,214 and $316,261, respectively (2022 - $524,931 and $1,875,392).

14. Earnings (loss) per share

The following table summarizes the calculation of the weighted average basic number of basic and diluted common shares to calculate the earnings (loss) per share as reported in the unaudited condensed consolidated interim statements of net loss and comprehensive loss:


KWESST MICRO SYSTEMS INC.
Notes to Condensed Consolidated Interim Financial Statements
Three and nine months ended June 30, 2023, and 2022
(Expressed in Canadian dollars, except share amounts)

    Three months
ended
June 30,
2023
    Three months
ended
June 30,
2022
    Nine months
ended
June 30,
2023
    Nine months
ended
June 30,
2022
 
Issued common shares,  beginning of period   4,272,113     735,491     773,225     699,509  
Effect of shares issued from:                        
December 2022 U.S. IPO and Canadian Offering (Note 13)   -     -     2,399,112     -  
Over-allotment Pre-Funded Warrants (Note 12)   -     -     147,974     -  
Debt settlements (Note 13)   -     -     40,923     130  
Conversion of stock units   337     4,249     11,033     2,246  
Exercise of options   213     -     70     -  
Exercise of warrants   -     2,286     2,368     7,761  
Acquisition of Police Ordnance (Note 4)   -     -     -     2,861  
Conversion of contingent shares (Note 4)   -     671     -     221  
Issuance of bonus shares (Note 10)   -     -     -     5,672  
Weighted average number of basic common shares   4,272,663     742,697     3,374,705     718,400  
                         
Dilutive securities:   -     -     -     -  
Weighted average number of dilutive common shares   4,272,663     742,697     3,374,705     718,400  

At June 30, 2023 and 2022, all dilutive securities were anti-dilutive because we incurred a net loss for the above periods.

As the $0.01 exercise price per Pre-Funded Warrant is non-substantive, the 199,000 Pre-Funded Warrants issued in the U.S. IPO are included in the basic net loss per share calculation.

15. Revenue

The following table, revenue from contracts with customers is disaggregated by primary geographical market, major products and service lines, and timing of revenue recognition.

  Three months     Three months     Nine months     Nine months  
    ended June     ended     ended     ended  
    30, 2023     June 30, 2022     June 30, 2023     June 30, 2022  
Major products / service lines                        
Digitization $ 61,823   $ 157,900   $ 325,827   $ 314,515  
Non-lethal   87,706     100,684     301,198     111,176  
Training and services       $ 23,495     -     39,169  
Other   740     353     1,980     1,288  
                         
  $ 150,269   $ 282,432   $ 629,005   $ 466,148  
                         
Primary geographical markets                        
United States $ 2,364   $ 27,607   $ 29,683   $ 48,658  
Canada   147,905     254,825     599,322     417,490  
                         
  $ 150,269   $ 282,432   $ 629,005   $ 466,148  
                         
Timing of revenue recognition                        
Products and services transferred over time $ 61,823   $ 181,395   $ 325,827   $ 353,684  
Products transferred at a point in time   88,446     101,037     303,178     112,464  
  $ 150,269   $ 282,432   $ 629,005   $ 466,148  


KWESST MICRO SYSTEMS INC.
Notes to Condensed Consolidated Interim Financial Statements
Three and nine months ended June 30, 2023, and 2022
(Expressed in Canadian dollars, except share amounts)

At June 30, 2023, KWESST's contracted not yet recognized revenue was $1,013,841 (2022 - $nil), of which 78.57% of this amount is expected to be recognized over the next 12 months with the remaining 21.43% expected to be recognized in 2 to 3 years.

For the three months ended June 30, 2023, three customers accounted for 48.67%, 31.47% and 9.68% (2022 - one customer accounted for 55.91%) of revenue. For the nine months ended June 30, 2023, four customers accounted for 35.84%, 14.11%, 11.63% and 8.03% (2022 - one customer accounted for 63.90%) of total revenue.

16. Net finance costs

The following table presents a breakdown of net finance costs for the following periods:

      Three months ended
June 30,
    Three months ended
June 30,
    Nine months ended
June 30,
    Nine months ended
June 30,
 
       2023     2022     2023     2022  
Finance costs from:                        
  Unsecured loans   -   $ 134,563   $ 453,983   $ 162,652  
  Accretion cost - accrued royalties liability   41,093     40,393     127,408     113,899  
  Lease obligations   7,810     7,562     20,895     23,590  
  Other   -     2,709     63,204     7,668  
Total financing costs   48,903     185,227     665,490     307,809  
Interest income   (8,077 )   (1,050 )   (59,550 )   (3,511 )
Gain on debt settlement (Note 10)   -     -     (430 )   -  
Gain on government grant (Note 10)   -     -     (10,000 )   -  
Net finance costs $ 40,826   $ 184,177   $ 595,510   $ 304,298  

17. Financial instruments

For the three and nine months ended June 30, 2023, there were no material changes to our financial risks as disclosed in Note 22 of the audited consolidated financial statements for the year ended September 30, 2022, except for the following:

Foreign currency risk

For the three and nine months ended June 30, 2023, certain of our revenues were denominated in U.S. dollar and we also procure certain raw materials denominated in U.S. dollar for product development. Further, we raised gross proceeds of US$14.1 million in the U.S. IPO and Canadian Offering (see Note 13), including the issuance of warrants with exercise price denominated in U.S. dollar (see Note 12). Accordingly, we are exposed to the U.S. dollar currency. Where a natural hedge cannot be achieved, a significant change in the U.S. dollar currency could have a significant effect on our financial performance, financial position and cash flows. Currently, we do not use derivative instruments to hedge its U.S. dollar exposure.

At June 30, 2023, we had the following net U.S. dollar exposure:

    Total USD  
Net liabilities in U.S. subsidiary $ (7,906 )
US denominated from other:      
Assets $ 518,330  
Liabilities   (1,555,898 )
    (1,037,568 )
Total net US dollar exposure $ (1,045,474 )
       
Impact to profit or loss if 5% movement in the US dollar $ (52,274 )


KWESST MICRO SYSTEMS INC.
Notes to Condensed Consolidated Interim Financial Statements
Three and nine months ended June 30, 2023, and 2022
(Expressed in Canadian dollars, except share amounts)

During the three and nine months ended June 30, 2023, we recorded a foreign exchange gain of $19,684 and a loss of $126,872, respectively (2022 - gain of $22,901 and $22,602).

Liquidity risk

At June 30, 2023, our contractual obligations were as follows:

                          5 years and  
Payment due:   Total   Within 1 Year   1 to 3 years   3 to 5 years     beyond  
Minimum royalty commitments $ 1,050,000   $ 150,000   $ 400,000   $ 500,000   $ 1,300,000  
Accounts payable and accrued liabilities   2,460,099     2,460,099     -     -     -  
Lease obligations   562,088     167,236     371,019     23,833     -  
Short-term rental obligations   35,158     35,158     -     -     -  
Total contractual obligations $ 4,107,345   $ 2,812,493   $ 771,019   $ 523,833   $ 1,300,000  

At June 30, 2023, we had $1.8 million in cash and negative $1.1 million in working capital (see Note 2(a)).

18. Supplemental cash flow information

The following table presents changes in non-cash working capital:

    Nine months     Nine months  
    ended     ended  
    June 30, 2023     June 30, 2022  
Trade and other receivables $ (126,176 ) $ 609,202  
Inventories   (1,197,449 )   (11,046 )
Prepaid expenses   (1,128,977 )   386,904  
Intangible assets   7,811     -  
Accounts payable and accrued liabilities   (928,614 )   934,025  
Contract liabilities   281,407     -  
Corporate taxes payable   -     (32,338 )
  $ (3,091,998 ) $ 1,886,747  

In addition to the non-cash items noted in Note 13, we also had the following non-cash items that were excluded from the Statements of Cash Flows for the nine months ended June 30, 2023:

 $2,924,880 non-cash share offering costs and $453,102 accounts payables as part of the net proceeds settlement at the closing of the U.S. IPO and Canadian Offering;

 250,000 warrants exercised in connection with the GhostStepTM acquisition in June 2020; and

 $529,504 of shares issued for vested RSUs and PSUs.

The following is a summary of non-cash items that were excluded from the Statements of Cash Flows for the nine months ended June 30, 2022:

 $19,000 debt settlement via common shares;

 $83,319 fair value of 61,264 contingent shares settled via common shares;

 $61,136 fair value of warrants exercised and transferred to share capital from warrants; and

 $125,000 for 250,000 warrants exercised in connection with the GhostStepTM acquisition in June 2020.


KWESST MICRO SYSTEMS INC.
Notes to Condensed Consolidated Interim Financial Statements
Three and nine months ended June 30, 2023, and 2022
(Expressed in Canadian dollars, except share amounts)

19. Commitments and contingencies

Except as noted below, there was no material change to the commitments and contingencies as disclosed in Note 26 of the audited consolidated financial statements for the year ended September 30, 2022.

In March 2023, we committed to signing a three-year lease agreement in Guelph, Canada for our non-lethal operations. The Company has yet to finalize the lease agreement. Terms of the accepted offer to lease included commencement on August 1, 2023, and expiring on June 30, 2026, for a total commitment of $208,285. The Company has not yet commenced occupation of the space, however, expects to in Q4.

20. Segmented information

Our Executive Chairman has been identified as the chief operating decision maker. Our Executive Chairman evaluates the performance of KWESST and allocates resources based on the information provided by our internal management system at a consolidated level. We have determined that we have only one operating segment.

At June 30, 2023, the majority of our property and equipment are located in Canada, including the right-of-use assets.

21. Subsequent Event

On July 21, 2023, the Company announced the closing of a US$5.688 million private placement in the United States. As part of the offering the Company issued 1,542,194 common shares at a price of US$2.26 (CAD$2.98) per common share and 930,548 pre-funded warrants at a price of us$2.26 (CAD$2.98) per pre-funded warrant, with each common share and pre-funded warrant being bundled with one common share purchase warrant of the Company. Each pre-funded warrant entitles the holder to acquire one common share at an exercise price of US$0.01 per common share, and each common warrant is immediately exercisable and entitles the holder to acquire one common share at an exercise price of US$2.66 (CAD$3.50) per common share for a period of 60 months following the closing of the offering.

ThinkEquity acted as sole placement agent for the Offering. As compensation for services rendered, the Company paid to ThinkEquity a cash fee of US$475,013.14 representing 8.5% of the aggregate gross proceeds of the Offering and issued 123,637 warrants to purchase a number of Common Shares (the "Placement Agent Warrants", representing 5% of the Common Shares and Pre-Funded Warrants sold in the Offering. The Placement Agent Warrants, will be exercisable, in whole or in part, immediately upon issuance and will expire 60 months after the closing date of the Offering at an initial exercise price of US$2.66 (CAD$3.50) per Common Share.

During the period ending June 30, 2023, and subsequent to period end, the Company reached settlements in two separate litigation cases involving a former employee and former consultant. The Company accrued approximately $267,000 related to these settlements at June 30. The Company expects to finalize all payments related to the settlements in Q4.